TransCelerate BioPharma and FDA/NIH Collaborate on Aligned Common Protocol Template

TransCelerate announced the availability of an enhanced technology enabled Common Protocol Template (CPT). This update to the CPT is in alignment with the common protocol template launched by the FDA and the NIH accessible here.

Translate ยป

Stay Connected to TransCelerate.